Drug Type Small molecule drug |
Synonyms Orthoflu, 오소플루노즈캡슐 |
Action antagonists, inhibitors, agonists |
Mechanism A1R antagonists(Adenosine A1 receptor antagonists), A2aR antagonists(Adenosine A2a receptor antagonists), COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (29 Jul 2025), |
Regulation- |
Molecular FormulaC10H16ClNO |
InChIKeyBALXUFOVQVENIU-KXNXZCPBSA-N |
CAS Registry345-78-8 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Common Cold | South Korea | 29 Jul 2025 |





